Form 4: Procept BioRobotics Director Antal Rohit Desai Reports Share Distribution and Ownership Changes

Director Antal Rohit Desai reports a pro rata distribution of shares from White Tailed Ptarmigan, LP and adjustments to beneficial ownership in Procept BioRobotics Corp.

Summary

• On May 3, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, resulting in Antal Rohit Desai directly acquiring 1,785,127 shares of Procept BioRobotics Corp.
• These shares were distributed for no consideration and were exempt from Section 16 under Rule 16a-13.
• Following the transaction, Desai directly owns 2,823,681 shares.
• Desai also indirectly owns shares through Kestrel Fund, L.P. (54,037 shares), Mallard Fund, L.P. (344,627 shares), and The 2:22 DNA Trust (216,323 shares).
• Desai disclaims beneficial ownership of shares held by CPMG Funds and The 2:22 DNA Trust, except to the extent of any pecuniary interest.
• Desai and his spouse are co-trustees of The 2:22 DNA Trust.
• Kent McGaughy, Jr. and CPMG, Inc. jointly report their beneficial ownership of these shares on a separate Form 4.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing changes in share ownership. It is neutral in tone and does not contain information that would strongly influence investor sentiment positively or negatively.

Industry Context

This filing is a routine disclosure of changes in beneficial ownership by a company insider, as required by the SEC. It doesn't provide specific insights into Procept BioRobotics' operational performance or strategic direction but offers transparency regarding the holdings of key individuals.

Stakeholder Impact

• The change in share ownership may be of interest to shareholders, providing insight into the holdings of a key insider.

Key Dates